302440 — SK Bioscience Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Market Cap
KR₩3tn
Enterprise Value
KR₩3tn
Revenue
KR₩651bn

Annual balance sheet for SK Bioscience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,645,663	1,475,506	1,268,841	1,156,508	904,701
Net Total Accounts Receivable
Net Total Receivables	48,135	89,661	22,342	188,396	132,943
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,837,804	1,783,694	1,382,969	1,576,673	1,246,125
Net Property, Plant And Equipment	220,983	293,057	315,923	982,607	1,130,387
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,110,123	2,141,931	1,852,439	2,843,596	2,955,744
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	459,952	380,037	135,620	310,589	326,238
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	508,811	400,229	148,584	1,041,031	1,166,944
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	1,601,312	1,741,702	1,703,855	1,802,565	1,788,800
Total Liabilities & Shareholders' Equity	2,110,123	2,141,931	1,852,439	2,843,596	2,955,744
Total Common Shares Outstanding